Results 261 to 270 of about 24,588 (279)

Omalizumab

Reactions Weekly
  +4 more sources

The clinical response to omalizumab in chronic spontaneous urticaria patients is linked to and predicted by IgE levels and their change

Allergy: European Journal of Allergy and Clinical Immunology, 2018
Marcus Maurer
exaly  

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

Journal of Allergy and Clinical Immunology: in Practice, 2019
Thomas B Casale, William Busse, Robert S Zeiger   +2 more
exaly  

Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria

New England Journal of Medicine, 2013
Marcus Maurer, Janice Canvin, Allen P Kaplan   +2 more
exaly  

Omalizumab facilitates rapid oral desensitization for peanut allergy

Journal of Allergy and Clinical Immunology, 2017
Sara V Little, Antonella Cianferoni, Jennifer Heimall   +2 more
exaly  

Omalizumab

Reactions Weekly, 2014
openaire   +2 more sources

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2019
Kenneth R Chapman, Frank C Albers, Xavier Muñoz Gall   +2 more
exaly  

Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma

Journal of Allergy and Clinical Immunology, 2001
William Busse
exaly  

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study

Journal of Investigative Dermatology, 2015
Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob   +2 more
exaly  

Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2018
Thomas B Casale
exaly